Form 8-K - Current report:
SEC Accession No. 0001232524-25-000061
Filing Date
2025-08-05
Accepted
2025-08-05 16:08:42
Documents
14
Period of Report
2025-08-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K jazz-20250805.htm   iXBRL 8-K 28303
2 EX-99.1 a2q25financialpr.htm EX-99.1 559044
6 GRAPHIC jazzpharma_logoxfullcolora.jpg GRAPHIC 120198
  Complete submission text file 0001232524-25-000061.txt   916262

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT jazz-20250805.xsd EX-101.SCH 1791
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT jazz-20250805_lab.xml EX-101.LAB 23507
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT jazz-20250805_pre.xml EX-101.PRE 13530
17 EXTRACTED XBRL INSTANCE DOCUMENT jazz-20250805_htm.xml XML 2906
Mailing Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN Ireland D04 E5W7
Business Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN Ireland D04 E5W7 353-1-634-7800
Jazz Pharmaceuticals plc (Filer) CIK: 0001232524 (see all company filings)

EIN.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33500 | Film No.: 251185016
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)